tiprankstipranks
Trending News
More News >
AlphaHelix Molecular Diagnostics AB (DE:4MB)
FRANKFURT:4MB
Germany Market

AlphaHelix Molecular Diagnostics AB (4MB) Financial Statements

Compare
0 Followers

AlphaHelix Molecular Diagnostics AB Financial Overview

AlphaHelix Molecular Diagnostics AB's market cap is currently €2.40M. The company's EPS TTM is €-0.008; its P/E ratio is -5.49; AlphaHelix Molecular Diagnostics AB is scheduled to report earnings on ―, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 21Dec 20Dec 19Dec 18Dec 17
Income Statement
Total Revenue
Gross Profit$ 17.88M$ 9.14M$ 7.49M$ 8.03M$ 10.66M
Operating Income$ 5.26M$ 1.55M$ -873.83K$ -1.18M$ -597.58K
EBITDA$ 6.52M$ 1.76M$ -613.60K$ -648.02K$ -153.10K
Net Income$ 5.16M$ 1.51M$ -983.25K$ -1.37M$ -766.45K
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 32.06M$ 9.90M$ 8.80M$ 10.01M$ 10.48M
Total Debt$ 900.00K$ 1.20M$ 2.33M$ 2.32M$ 2.18M
Net Debt$ -4.96M$ -220.10K$ 1.92M$ 2.03M$ 2.05M
Total Liabilities$ 9.95M$ 6.90M$ 7.31M$ 7.54M$ 6.64M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ 1.63M$ 1.84M$ 69.02K$ 12.68K$ -785.95K
Operating Cash Flow$ 1.63M$ 1.84M$ 69.02K$ 112.27K$ -56.63K
Investing Cash Flow
Financing Cash Flow
Currency in USD

AlphaHelix Molecular Diagnostics AB Earnings and Revenue History

AlphaHelix Molecular Diagnostics AB Debt to Assets

AlphaHelix Molecular Diagnostics AB Cash Flow

AlphaHelix Molecular Diagnostics AB Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.